Drugs / multipotent mesenchymal stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02145923 | May 2014 → Jun 2016 | chemotherapy-induced toxicity, enterocolitis | Burnasyan Federal Medical Biophysical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | multipotent mesenchymal stromal cells | “Patient will receive bone marrow derived allogeneic multipotent mesenchymal stromal cells infusion 48 hours after last administration of cytotoxic agent .” NCT02145923 ↗ |
| Route | Intravenous | “bone marrow derived allogeneic multipotent mesenchymal stromal cells intravenous infusion” NCT02145923 ↗ |